Table 3

Association of socioeconomic status with changes in heart failure phenotype and treatment over 1 year

IMD quintileP value
12345
n=60n=84n=68n=83n=113
Worsening NYHA class (% (n))20 (12)11 (9)13.2 (9)18.1 (15)9.9 (11)0.27
Change in systolic BP−3.1 (3.5)−4.4 (2.6)6.5 (3.1)−0.5 (2.7)−1.2 (2.6)0.6
Change in heart rate−2.3 (2.5)−5.5 (2.3)−5.9 (2.3)−0.4 (1.9)−5.8 (2.2)0.32
Change in haemoglobin−0.6 (0.2)−0.6 (0.1)−0.5 (0.2)−0.4 (0.1)−0.5 (0.2)0.82
Change in eGFR−0.2 (1.0)−4.2 (1.7)−1.6 (1.0)−2.9 (1.0)−0.4 (1.1)0.12
Percent of baseline LV end-systolic dimension98.4 (2.5)92.8 (2.3)95.3 (1.9)97.5 (2.1)90.4 (1.6)0.028
Change in ramipril equivalent dose1.3 (0.5)1.0 (0.4)1.2 (0.3)1.0 (0.4)1.3 (0.4)0.95
Change in bisoprolol equivalent dose1.1 (0.5)1.8 (0.4)2.0 (0.4)1.9 (0.3)2.0 (0.3)0.6
Change in furosemide equivalent dose−11.9 (5.9)−3.7 (4.8)−2.5 (4.8)14.6 (5.6)0.4 (4.8)0.016
  • BP, blood pressure; eGFR, estimated glomerular filtration rate; IMD, Index of Multiple Deprivation; LV, left ventricular; NYHA, New York Heart Association.